Th1 and Th2 cells in HIV infection

Chemical Immunology

Volumn 63, Issue , 1996, Pages 138-157

  Manetti, R ^a   Annunziato, F ^a   Gianno V ^a   Tomasevic L ^a   Beloni, L ^a   Mavilia, C ^a   Maggi, E ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Istituto di Clinica Medica 3   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE;

GRANULOMA; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; LUNG ALVEOLUS MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION; IMMUNOLOGY; TH1 CELL; TH2 CELL; VIROLOGY;

HIV INFECTIONS; HUMANS; TH1 CELLS; TH2 CELLS;

EID: 0030012023     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319483     Document Type: Review

References (83)

1. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Immunol 1993,328:327-335
2. Romagnani S: Immunologic and clinical aspects of human immunodeficiency virus infection. Allergy 1994;49:685-695.
3. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, Letvin NL: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus in macaques J Virol 1994;68:2362-2370.
4. Rosemberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: Cytokine induction of HIV expression. Immunol Today 1990;11:176-180.
5. Poli G, Fauci AS: The effect of cytokines and pharmacologic agents on chronic HIV infection AIDS Res Hum Retrovir 1992;8:191-197.
6. Poli G, Kinter AL, Vicenzi E, Fauci AS. Cytokine regulation of acute and chronic HIV infection in vitro: From cell lines to primary mononuclear cells. Res Immunol 1994;145.571-730.
7. Ladhevirta J, Maury CP, Teppo AM, Repo H: Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-291.
8. Wright SC, Jewett A, Mitsuyasu R, Bonavida B: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988;141: 99-104.
9. Agostini C, Trentin L, Zambello R, Semenzato G: HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Resp Dis 1993;147:1038-1049
10. Poli G, Bressler P, Kinter A, Duh E, Timmer WL, Rabson A, Justement JS, Stanely S, Fauci AS: IL-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with TNF by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172: 151-158.
11. Serwadda D, Sewankambo NK, Carswell JW, Bayley AC, Tedder RS, Weiss RA, Mugerwa A, Lwegaba G, Kirya R, Downing RG, Clayden SA, Dalgeish AG. Slim disease: A new disease in Uganda and its association with HTLV-III infection. Lancet 1985:ii:849-855.
12. Macchia D, Almerigogna F, Ravina A, Maggi E, Romagnani S. Membrane tumor necrosis factor-a is involved in the polyclonal B cell activation induced by HIV-infected T cells. Nature 1993;363: 464-466.
13. Macchia D, Parronchi R, Piccinni M-P, Simonelli C, Mazzetti M, Ravina A, Milo D, Maggi E, Romagnani S: In vitro infection with HIV enables human CD4 + T cell clones to induce noncognate contact-dependent polyclonal B cell activation. J Immunol 1991,146 3413-3418.
14. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-484.
15. Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, Di Francesco C, Cipriani A, Francavilla E, Semenzato G: Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type-1-infected patients J Infect Dis 1992;166:731-737.
16. Kekow J, Wachsman W, McCutchan JA, Cronin M, Carson DA, Lotz M: Transforming growth factor-beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency infection. Proc Natl Acad Sci USA 1990,87:8321-8325.
17. Del Prete GF, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production J Immunol 1993,150:353-360.
18. Chehimi J, Star SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-1366.
19. Romagnani S: Human Th1 and Th2: Doubt no more. Immunol Today 1991;12:256-257.
20. Del Prete GF, De Carli M, Mastromauro C, Macchia D, Biagiotti R, Ricci M, Romagnani S: Purified protein derivative of Mycobacterium tuberculosis and excretory/secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-350.
21. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994,12:227-257.
22. Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, Kapsenberg M: Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-4656.
23. Parronchi P, Macchia D, Piccinni M-P, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S: Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88: 4538-4543.
24. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convitt J, Modlin RL, Bloom BR: Differing lymphokine profiles and functional subsets of human CD4+ and CD8+ T cell clones Science 1991;254:279-281.
25. Del Prete GF, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993;23:1445-1449.
26. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G: Borrelia burgdorferi activates a T helper Type 1-like T cell subset in Lyme arthritis. J Exp Med 1991;174.593-601.
27. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM: Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today 1991;12:392-395.
28. Maggi E, Biswas P, Del Prete GF, Parronchi P, Macchia D, Simonelli C, Emmi L, De Carli M, Tiri A, Ricci M, Romagnani S: Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991;146:1169-1174.
29. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-1546.
30. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colonystimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992,148.2390-2394.
31. Van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML: High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991, 97:389-394.
32. Swain SL, McKenzie DT, Weinberg D, Hancock W: characterization of T helper 1 and 2 cell subsets in normal mice: Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol 1988,141: 3445-3455.
33. Weinberg AD, English ME, Swain SLL Distinct regulation of lymphokine production is found in fresh versus in vitro primed murine helper cells. J Immunol 1990;144:1800-1806.
34. StreetNE, Schumacher JH, Fong TAT, Bass H, Fiorentino DF, Leverah JA, MosmannTR: Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 1990;144:1629-1639.
35. Reiner SL, Wang ZE, Hatan F, Scott P, Locksley RM: Th1 and Th2 cell antigen receptors in experimental leishmaniasis. Science 1993;259:1457-1460
36. Gajewski TF, Joyce J, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J Immunol 1989;143:15-22.
37. Scott P: Host and parasite factors regulating the development of CD4+ subsets in experimental cutaneous leishmaniasis. Res Immunol 1991;142:32-35
38. Coffman RL, Chatelain R, Leal LMCC, Varkila K: Leishmania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation Res Immunol 1991;142:36-39.
39. Romagnani S: Induction of Th1 and Th2 response: A key role for the 'natural' immune response? Immunol Today 1992;13 379-380.
40. Hsieh C-S, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
41. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th 1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
42. Seder RA, Paul WE, Davis MM, Fazekas de St Groth B: The presence of interleukin 4 during in vitro priming determines the lymphocyte-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992;176:1091-1098.
43. Bendelac A, Schwartz RH: CD4+ and CD8+ T cells acquire specific lymphokine secretion potentials during thymic maturation. Nature 1991;353:68-71.
44. Ben Sasson SZ, LeGros G, Conrad DH. Finkelman FD. Paul WE: Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete IL-4 and other lymphokines. Proc Natl Acad Sci USA 1990;87 1421-1425.
45. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM: Reciprocal expression of interferon gamma or IL-4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-67.
46. Scott P, Pearce E, Cheever AW, Coffman RL, Sher A: Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 1989;112:61-182.
47. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-280.
48. Clerici M, Shearer GM: A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
49. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA. Shearer JM: Cell mediated immune response to human immunodeficiency virus type 1 (HIV-1) in seronegative homosexuals with recent sexual exposure to HIV-1. J Infect Dis 1992;165: 1012-1019.
50. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-sero-positive individuals. J Clin Invest 1993;91.759-765.
51. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM: Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93:768-775.
52. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Lynn TA, Blatt SP, Dolan MJ, Hendrix CW Wolf SF, Shearer GM: Restoration of HIV-specific cell-mediated immune response by interleukin-12 in vitro Science 1993;262:721-1724
53. Maggi E, Mazzetti M, Ravina A, Manetti R, De Carli M, Annunziato F, Piccinni MP, Carbonari M, Pesce AM. Del Prete G. Romagnani S: HIV can favor a Th1/Th0 shift and preferentially replicates in Th2 and Th0 cells Science 1994;265:244-248.
54. Emilie D, Fior R, Llorente L, Marfaing-Koka A, Peuchmaur M, Devergne O, Jarrousse B, Wijdenes J, Boue F, Galanaud P: Cytokines from lymphoid organs of HIV-infected patients: Production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol Rev 1994;140 5-28.
55. Graziosi C, Pantaleo G, Ganett KR, Demarest JF, Cohen OJ, Fauci AS: Constitutive expression of cytokines in lymphoid tissue of HIV-infected individuals: Lack of evidence for dichotomy of Th1 and Th2 predominance. Science 1994;265:248-252.
56. Fan J, Bass HZ, Fahey JL: Elevated IFN-g and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993,151:5031-5040.
57. Romagnani S, Maggi E, Del Prete G, Manetti R, Ravina A, Annunziato F, De Carli M, Mazzetti M, Piccinni MP, D'Elios MM, Parronchi P: Role for Th1/Th2 cytokines in HIV infection. Immunol Rev 1994;140:73-92.
58. Zurawski G, de Vries JE: Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
59. Romagnani S. Regulation and deregulation of human IgE synthesis. Immunol Today 1990;11. 316-321.
60. Meyaard L, Otto SA. Keet IPM, van Lier RAW, Miedema F: Changes in cytokine secretion patterns of CD4+ T cell clones in human immunodeficiency virus infection. Blood 1994;34:4262-4268.
61. Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dvekster G, Meltzer MS, Dieffenbach C: A selective defect of interferon a production in human immunodeficiency virus-infected monocytes. J Exp Med 1990;172:1433-1438.
62. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
63. Margolick JB, Volkman DL, Lane CH, Fauci AS: Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome: Evidence for an abnormality affecting individual helper and suppressor T cells. J Clin Invest 1985;76:709-715.
64. Maggi E, Macchia D, Parronchi P, Mazzetti M, Ravina A, Milo D, Romagnani S: Reduced production of interleukin-2 and interferon-gamma and enhanced helper activity for IgG synthesis by cloned CD4+ T cells from patients with AIDS. Eur J Immunol 1987;17:1685-1690.
65. Paganelli R, Scala E, Ansotegui IJ, Mezzaroma I, Pinter E, Ferrara P, D'Offizi GP, Aiuti F: Hyper-IgE syndrome induced by HIV infection Immunodeficiency 1993;4:149-154
66. Raiteri R, Sinicco A, Gioannini P, Picciotto F, Marietti G, Novero D, Pippione M. Job's-like syndrome in HIV-1 infection. J Dermatol 1993;3:355-360.
67. Maggi E, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Piccinni MP, Parronchi P, Sampognaro S, Giannarini L, Zuccati G, Romagnani S: Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994; 180:489-495.
68. Erard F, Wild M-T, Garcia-Sanz JA, Le Gros G: Switch of CD8 T cells to noncytolytic CD8-CD4-cells that make TH2 cytokines and help B cells. Science 1993;260:1802-1805.
69. Mak TW, Rahemtulla A, Schilham M, Koh DR, Fung-Leung WP: Generation of mutant mice lacking expression of CD4 or CD8 gene targeting. Adv Exp Med Biol 1992;323.73-77.
70. Carbonari M, Sbarigia SE, Cibati M, Fiorilli M: Optimization of PCR performance. Trends Genet 1993;9:42-43.
71. Vyakarnam A: Mechanisms for an opposite role for Th1/Th2 cells in AIDS. Res Immunol 1994; 145:618-624.
72. Trinchieri G: Proc 'T cell subsets in infection and autoimmune diseases'. Symp, No. 195. Ciba Foundation, in press.
73. Mackewicz C, Levy JA: CD8+ cells anti-HIV activity: Nonlytic suppression of viral replication. AIDS Res Hum Retrovir 1992;8:1039-1049.
74. Brinchmann JE, Gaudernack G, Vertdal F: CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. J Immunol 1990;144:2961-2966.
75. Grace H, Wong GHW, Goeddel DV. Tumor necrosis factor α and β inhibit virus replication and synergize with interferons. Nature 1986;323:819-822.
76. Romagnani S, Maggi E, Del Prete GF: HIV can induce a Th1 to Th0 shift and preferentially replicates in CD4+ T-cell clones producing Th2-type cytokines. Res Immunol 1994;145:611-617.
77. Smith C, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK. Cosman D, Goodwin RG: A receptor for necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-1023.
78. Del Prete GF, Maggi E, Pizzolo G, Romagnani S: CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995;16:76-79.
79. Del Prete GF, De Carli M, Almerigogna F, Daniel KC, D'Elios MM, Zancuoghi D, Vinante E, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995;9:81-86.
80. Manetti R, Annunziato F, Biagiotti R, Giudizi M-G, Piccinni M-P, Giannarini L, Sampognaro S, Parronchi P, Vinante F, Pizzolo G, Maggi E, Romagnani S: CD30 expression by CD8+ T cells producing type 2 helper cytokines: Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 1994;180:2407-2411
81. Pizzolo G, Vinante F, Morosato L, Nadali G, Chilosi M, Gandini G, Sinicco A, Raiteri S, Semenzato G, Stein H, Perona G: High serum levels of soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994;8:793-797.
82. Romagnani S, Maggi E. Th1 versus Th2 in AIDS. Curr Opin Immunol 1994;1:616-622.
83. Duh EJ, Maury WJ, Folks TM, Fauci AS: Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989;86:5974-5978.